✦ LIBER ✦

[586] SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BILB1941, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

✍ Scribed by A. Erhardt; H. Wedemeyer; Y. Benhamou; C. Moellekens; X. Forns; S. Pol; J.L. Calleja; S. Ross; H.C. Spangenberg; J. Garcia-Samaniego; M. Fuchs; J. Enriquez; T. Wiegand; J. Stern; K. Wu; G. Nehmiz; J. Steffgen

Book ID: 117375678
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 153 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)62184-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1054 SAFETY, PHARMACOKINETICS AND ANTIVI

1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

✍ Larrey, D.; Benhamou, Y.; Lohse, A.W.; Trepo, C.; Moelleken, C.; Bronowicki, J.- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

294 Safety and antiviral effect of BILN

294 Safety and antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, genotype 1, and liver cirrhosis

✍ Heiner Wedemeyer; Andreas Erhardt; Wolff Schmiegel; Holger Hinrichsen; Ricardo C 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

136 Antiviral effect of BILN 2061, a nov

136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1

✍ Markus Reiser; Holger Hinrichsen; Yves Benhamou; Roel Sentjens; Heiner Wedemeyer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB